Resumen de acción AMBU B
Ambu A/S desarrolla, produce y vende dispositivos médicos a hospitales, clínicas y servicios de rescate de todo el mundo.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en AMBU B a partir de nuestros controles de riesgos.
Competidores de Ambu A/S
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | kr.137.90 |
| 52 Week High | kr.139.90 |
| 52 Week Low | kr.65.62 |
| Beta | 0.74 |
| 1 Month Change | 13.78% |
| 3 Month Change | 17.86% |
| 1 Year Change | 29.85% |
| 3 Year Change | -39.57% |
| 5 Year Change | 47.80% |
| Change since IPO | 7,952.56% |
Noticias y actualizaciones recientes
Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity
Apr 06
Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)
Mar 14Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates
Feb 01Recent updates
Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity
Apr 06Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)
Mar 14Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates
Feb 01A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price
Jan 02Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?
Oct 31Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends
Sep 22Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?
Aug 19Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?
Jul 12Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture
Jun 22Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet
May 07Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture
Mar 24We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt
Jan 20Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around
Dec 08Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?
Sep 23Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends
Sep 08We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt
Aug 21Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital
Jun 06These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively
May 19Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?
Jan 23Are Investors Undervaluing Ambu A/S (CPH:AMBU B) By 27%?
Dec 12Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?
Oct 04Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around
Jul 20Here's Why Ambu (CPH:AMBU B) Can Manage Its Debt Responsibly
May 14Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?
Apr 19Rentabilidad de los accionistas
| AMBU B | DK Medical Equipment | Mercado DK | |
|---|---|---|---|
| 7D | 1.0% | 1.9% | -0.1% |
| 1Y | 29.8% | 6.3% | 36.2% |
Rentabilidad vs. Industria: AMBU B superó al sector Danish Medical Equipment , que obtuvo un rendimiento del -5.8% el año pasado.
Rentabilidad vs. Mercado: AMBU B obtuvo unos resultados inferiores a los del mercado Danish, que fueron del 36.8% el año pasado.
Volatilidad de los precios
| AMBU B volatility | |
|---|---|
| AMBU B Average Weekly Movement | 5.7% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in DK Market | 9.8% |
| 10% least volatile stocks in DK Market | 2.9% |
Precio estable de las acciones: AMBU B no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de AMBU B (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1937 | 4,600 | Britt Jensen | www.ambu.com |
Ambu A/S desarrolla, produce y vende dispositivos médicos a hospitales, clínicas y servicios de rescate de todo el mundo. La empresa ofrece productos de anestesia, monitorización de pacientes y diagnóstico. También ofrece productos de endoscopia, como broncoscopios, rinolaringoscopios, duodenoscopios, cistoscopios y unidades de visualización; y productos de neurología, como electrodos de EEG y EMG, inyecciones guiadas por EMG y productos de monitorización intraoperatoria.
Resumen de fundamentos de Ambu A/S
| Estadísticas fundamentales de AMBU B | |
|---|---|
| Capitalización bursátil | kr.37.08b |
| Beneficios(TTM) | kr.367.00m |
| Ingresos (TTM) | kr.5.08b |
100.1x
Ratio precio-beneficio (PE)7.2x
Ratio precio-ventas (PS)¿Está AMBU B sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de AMBU B | |
|---|---|
| Ingresos | kr.5.08b |
| Coste de los ingresos | kr.2.14b |
| Beneficio bruto | kr.2.94b |
| Otros gastos | kr.2.57b |
| Beneficios | kr.367.00m |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
Aug 30, 2024
| Beneficios por acción (BPA) | 1.38 |
| Margen bruto | 57.91% |
| Margen de beneficio neto | 7.23% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado AMBU B a largo plazo?
Ver rendimiento histórico y comparativa